Showing results (61-70 of 259) with videos related to
Sort By:
Pageof 26
Cancer Treatment Reports|May 1, 1982
5-FU and allopurinol: toxicity modulation and phase II results in colon cancerJ F Kroener, F Saleh, S B HowellJournal of Inorganic Biochemistry|January 8, 2000
The role of DNA mismatch repair in cisplatin mutagenicityX Lin, H K Kim, S B HowellCancer Research|December 1, 1990
Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitroD R Shalinsky, M Andreeff, S B HowellCancer Treatment Reports|February 1, 1985
Intracavitary cisplatin chemotherapy for mesotheliomaC E Pfeifle, S B Howell, M MarkmanCancer Chemotherapy and Pharmacology|January 1, 1981
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexateS B Howell, S J Mansfield, R TaetleAnticancer Research|November 1, 1994
In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenograftsR Jamshidipour, E B Pinho, S B HowellAmerican Journal of Obstetrics and Gynecology|June 15, 1985
Intraperitoneal chemotherapy for advanced ovarian cancerW E Lucas, M Markman, S B HowellCancer Treatment Reports|October 1, 1982
Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acidsS B Howell, S Gill, H L ElfordCancer Drug Delivery|January 1, 1984
Combination intracavitary chemotherapy for malignant pleural diseaseM Markman, S B Howell, M R GreenCancer Research|October 1, 1979
Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude miceS B Howell, R S Jenkins, J StreifelPageof 26